SSB 1169: Relating to nonopioid drugs on the medical assistance preferred drug list, and health carriers’ development of a pain management access plan

What it does

This bill relates to nonopioid drugs on the medical assistance preferred drug list, and health carriers’ development of a pain management access plan. _____ for an opioid or narcotic drug for the treatment or management of pain on the preferred drug list. Impermissible disadvantaging or discouragement of a nonopioid drug includes designating the nonopioid drug as a nonpreferred drug if any opioid or narcotic is designated as a preferred drug, and establishing more restrictive or extensive utilization controls for a nonopioid drug than the least restrictive or extensive utilization controls applicable to an opioid or narcotic drug.

Senate subcommittee · named March 3, 2025

• Sen. Mike Klimesh (R) · mike.klimesh@legis.iowa.gov
• Sen. Kevin Alons (R) · kevin.alons@legis.iowa.gov
• Sen. Mike Zimmer (D) · mike.zimmer@legis.iowa.gov

Lobbying · 6 for, 2 against

For: Iowa Behavioral Health Association (IBHA); Iowa Independent Physician Group; Iowa Medical Society; Iowa Mental Health Advocacy; Iowa Physician Assistant Society; Vertex Pharmaceuticals

Against: Cigna Corporate Services, LLC; Federation of Iowa Insurers

In plain words

1. February 20, 2025Filed in the Senate and sent to the Health and Human Services committee
2. February 20, 2025Senate subcommittee named: Klimesh, Campbell and Zimmer
3. March 3, 2025Senate subcommittee named: Klimesh, Alons and Zimmer
4. March 4, 2025Subcommittee recommended passing it with changes